Celltrion's auto-immune disease biosimilar wins further approval in Europe

22 February 2022 - South Korean pharmaceutical giant Celltrion said Tuesday that a high concentration version of its auto-immune disease ...

Read more →

EMA and Korean Ministry of Food and Drug Safety to share confidential COVID-19 information

30 June 2020 - EMA and the Ministry of Food and Drug Safety of the Republic of Korea have signed ...

Read more →